Alexis Dormandy, Oxford Science Enterprises CEO
Oxford Science Enterprises collects $300M to offer spinouts 'scale-up capital'
For the past seven years, biotech spinouts from the University of Oxford have often tapped into a reliable source of investments from Oxford Science Enterprises …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.